{"schema_version":"secwatch.filing_event.v1","accession":"0001534120-26-000016","form_type":"8-K","ticker":"AVTX","cik":"0001534120","company_name":"Avalo Therapeutics, Inc.","filed_at":"2026-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.358504+00:00","generated_at":"2026-05-15T08:37:04.753981+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Two Avalo Therapeutics directors to not stand for re-election at 2026 Annual Meeting","bullets":["Dr. Jonathan Goldman and Mitchell Chan will not stand for re-election to the Board at the 2026 Annual Meeting.","They will continue to serve as board members until the 2026 Annual Meeting.","Decisions are not due to any disagreement with the Company regarding operations, policies, or practices.","The Board expressed gratitude for their service and contributions."],"urls":{"canonical":"https://secwatch.observer/filing/0001534120-26-000016","json":"https://secwatch.observer/filing/0001534120-26-000016.json","markdown":"https://secwatch.observer/filing/0001534120-26-000016.md","text":"https://secwatch.observer/filing/0001534120-26-000016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000016/0001534120-26-000016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000016/avtx-20260323.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:37:04.753981+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}